SCHEMBL21924038

SCHEMBL21924038

BC(B)(Nc1cccc(C=O)c1C(B)(O)N(C)C1(B)CCC(=O)NC1=O)c1ccc(C(B)(B)N2C(B)(B)C(B)(B)OC(B)(B)C2(B)B)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23938908 0.93 — —
SCHEMBL23938887 0.81 — —
SCHEMBL21927116 0.80 DDB1 (0.30) —
SCHEMBL21925254 0.76 — —
SCHEMBL21281361 0.67 — —
SCHEMBL21281476 0.66 DDB1 (0.30) —
SCHEMBL19310220 0.64 — —
SCHEMBL19310143 0.63 — —
SCHEMBL21925688 0.62 — —
SCHEMBL19310114 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2020-04-29 — — EP disclosed
Send feedback